ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AB02 | BioTech | Infliximab - 120mg/ml | 11287 | 24222/1 | REMSIMA SC | 120mg/ml | 1 | Injectable solution | SC | Droguerie Mercury S.A.L. | Vetter Pharma- Fertigung GmbH & Co KG under Licensed from Celltrion Inc. | Germany | 52,597,003 L.L | 10.71 | E1 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AB02 | BioTech | Infliximab - 120mg/ml | 11285 | 24722/1 | REMSIMA SC | 120mg/ml | 4 | Injectable solution | SC | Droguerie Mercury S.A.L. | Vetter Pharma- Fertigung GmbH & Co KG under Licensed from Celltrion Inc. | Germany | 179,063,666 L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
L04AB02 | BioTech | Infliximab - 120mg/ml | 11286 | 24322/1 | REMSIMA SC | 120mg/ml | 2 | Injectable solution | SC | Droguerie Mercury S.A.L. | Vetter Pharma- Fertigung GmbH & Co KG under Licensed from Celltrion Inc. | Germany | 91,457,321 L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |